EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting

Guido Freckmann iD, Manuel Eichenlaub iD, Delia Waldenmaier iD, Stefan Pleus iD, Stephanie Wehrstedt, Cornelia Haug, Lilian Witthauer iD, Johan Jendle iD, Rolf Hinzmann iD, Andreas Thomas iD, Elisabet Eriksson Boija, Konstantinos Makris iD und 5 weitere

Journal of Diabetes Science and Technology · 2023-11 · 17 (6) · 1506-1526

DOI: 10.1177/19322968231190941 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Journal of Diabetes Science and Technology, online erschienen am 20.08.2023. Verfasst von Guido Freckmann und 16 weiteren Autor:innen. Beteiligte Einrichtung: IFCC Scientific Division - Working Group on Continuous Glucose Monitoring. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Diabetes Center Berne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of different approaches for design and results presentation of studies for the clinical performance evaluation of continuous glucose monitoring (CGM) systems has long been recognized as a major challenge in comparing their results. However, a comprehensive characterization of the variability in study designs is currently unavailable. This article presents a scoping review of clinical CGM performance evaluations published between 2002 and 2022. Specifically, this review quantifies the prevalence of numerous options associated with various aspects of study design, including subject population, comparator (reference) method selection, testing procedures, and statistical accuracy evaluation. We found that there is a large variability in nearly all of those aspects and, in particular, in the characteristics of the comparator measurements. Furthermore, these characteristics as well as other crucial aspects of study design are often not reported in sufficient detail to allow an informed interpretation of study results. We therefore provide recommendations for reporting the general study design, CGM system use, comparator measurement approach, testing procedures, and data analysis/statistical performance evaluation. Additionally, this review aims to serve as a foundation for the development of a standardized CGM performance evaluation procedure, thereby supporting the goals and objectives of the Working Group on CGM established by the Scientific Division of the International Federation of Clinical Chemistry and Laboratory Medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseDiabetes Mellitus, Type 1HumansBlood Glucose Self-Monitoring

Stichwörter der Autor:innen

accuracyclinical performance evaluationcontinuous glucose monitoringstudy design

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • IFCC Scientific Division - Working Group on Continuous Glucose Monitoring.
  • Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
  • Diabetes Center Berne, Bern, Switzerland.
  • Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital Bern, Bern University Hospital and University of Bern, Bern, Switzerland.
  • School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Roche Diabetes Care GmbH, Mannheim, Germany.

ORCID-Profile: Guido Freckmann, Manuel Eichenlaub, Delia Waldenmaier, Stefan Pleus, Lilian Witthauer, Johan Jendle, Rolf Hinzmann, Andreas Thomas, Konstantinos Makris, Nam Tran, David C Klonoff, James H Nichols

Förderung

  • Diabetes Center Berne

Zitieren

APA

Freckmann, G., Eichenlaub, M., Waldenmaier, D., Pleus, S., Wehrstedt, S., Haug, C., Witthauer, L., Jendle, J., Hinzmann, R., Thomas, A., Eriksson Boija, E., Makris, K., Diem, P., Tran, N., Klonoff, D. C., Nichols, J. H., & Slingerland, R. J. (2023). Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting. Journal of Diabetes Science and Technology, 17(6), 1506-1526. https://doi.org/10.1177/19322968231190941

Vancouver

Freckmann G, Eichenlaub M, Waldenmaier D, Pleus S, Wehrstedt S, Haug C, et al. Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting. Journal of Diabetes Science and Technology. 2023;17(6):1506-1526. doi:10.1177/19322968231190941

BibTeX
@article{Freckmann2023,
  author = {Freckmann, Guido and Eichenlaub, Manuel and Waldenmaier, Delia and Pleus, Stefan and Wehrstedt, Stephanie and Haug, Cornelia and Witthauer, Lilian and Jendle, Johan and Hinzmann, Rolf and Thomas, Andreas and Eriksson Boija, Elisabet and Makris, Konstantinos and Diem, Peter and Tran, Nam and Klonoff, David C and Nichols, James H and Slingerland, Robbert J},
  title = {Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting},
  journal = {Journal of Diabetes Science and Technology},
  year = {2023},
  volume = {17},
  number = {6},
  pages = {1506--1526},
  doi = {10.1177/19322968231190941}
}
Kostenlos starten →